World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
23838
World Ranking
1183
National Ranking
44

Medicine

D-Index
88
Citations
23835
World Ranking
13328
National Ranking
508

Guido Forni publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guido Forni sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 367 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guido Forni D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guido Forni sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Guido Forni is affiliated with the University of Turin in Italy. Their research intersects the fields of Medicine and Mathematics, with a focus on Modeling and Simulation as a primary subfield. Additional subfields include Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology, and Genetics.

The main topics of Guido Forni's work encompass:

  • COVID-19 epidemiological studies
  • Mathematical and Theoretical Epidemiology and Ecology Models
  • SARS-CoV-2 and COVID-19 Research
  • Immune responses and vaccinations
  • COVID-19 Clinical Research Studies
  • Mathematical Biology Tumor Growth
  • Evolution and Genetic Dynamics

Recent publications by Guido Forni include:

  • COVID-19 vaccines: where we stand and challenges ahead, 2021, Cell Death and Differentiation

Other frequently cited relevant works connected with this research area, though with different authorship, include:

  • A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world, 2020, CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies)
  • Biological fluid dynamics of airborne COVID-19 infection, 2020, RENDICONTI LINCEI
  • Ten things we learned about COVID-19, 2020, Intensive Care Medicine
  • A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world, 2020, Mathematical Models and Methods in Applied Sciences

Guido Forni frequently collaborates with the following researchers:

  • Nicola Bellomo
  • Alberto Mantovani
  • Mark A. J. Chaplain
  • Giovanni Dosi
  • Damián Knopoff

Their research has appeared in several academic venues including:

  • Cell Death and Differentiation
  • CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies)
  • RENDICONTI LINCEI
  • Mathematical Models and Methods in Applied Sciences
  • Intensive Care Medicine

Best Publications

  • A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

    Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

  • Systemic spread is an early step in breast cancer.

    Yves Hüsemann;Jochen B. Geigl;Falk Schubert;Piero Musiani

  • The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

    Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

  • DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

    Stefania Rovero;Augusto Amici;Emma Di Carlo;Roberto Bei

  • Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

    Cecilia Melani;Claudia Chiodoni;Guido Forni;Mario P. Colombo

  • Vaccines for tumour prevention

    Pier-Luigi Lollini;Federica Cavallo;Patrizia Nanni;Guido Forni

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • 2011: the immune hallmarks of cancer

    Federica Cavallo;Carla De Giovanni;Patrizia Nanni;Guido Forni

  • Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

    Mario P. Colombo;Guido Forni

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development

    Elisa Ciraolo;Manuela Iezzi;Romina Marone;Stefano Marengo

  • Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

    Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • Distribution of interferon-γ receptor in human tissues

    Guido Valente;Laurence Ozmen;Francesco Novelli;Massimo Geuna

  • Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

    Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

  • Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.

    Mario P. Colombo;Andrea Modesti;Giorgio Parmiani;Guido Forni

  • Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

    Giorgio Cortesina;Antonella de Stefani;Mirella Giovarelli;Maria Grazia Barioglio

  • CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

    Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

  • Interferon‐γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death

    Paola Bernabei;Eliana M. Coccia;Laura Rigamonti;Marita Bosticardo

  • Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

    Federica Cavallo;Paola Signorelli;Mirella Giovarelli;Piero Musiani

  • α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

    Yoshihiro Hayakawa;Stefania Rovero;Guido Forni;Mark J. Smyth

Frequent Co-Authors

Federica Cavallo
Federica Cavallo University of Turin
Mirella Giovarelli
Mirella Giovarelli University of Turin
Piero Musiani
Piero Musiani University of Chieti-Pescara
Andrea Modesti
Andrea Modesti University of Rome Tor Vergata
Emma Di Carlo
Emma Di Carlo University of Chieti-Pescara
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Santo Landolfo
Santo Landolfo University of Turin
Patrizia Nanni
Patrizia Nanni University of Bologna
Francesco Novelli
Francesco Novelli University of Turin
Angela Santoni
Angela Santoni Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can expand career opportunities. Many students pivot to nursing through online accelerated programs designed for non-nurses. These options provide a streamlined path to enter the healthcare profession quickly. If you’re looking for a faster route, 12-month accelerated nursing programs offer intensive study schedules that prepare you for the nursing workforce in just one year.

Entry into nursing can also be through Licensed Practical Nurse (LPN) programs, which vary in accessibility. Knowing which LPN programs are easiest to get into can help prospective students identify programs that align with their academic profiles and career goals.

For advanced practice roles, online nurse practitioner degrees provide a flexible pathway for professionals aiming to specialize and expand their clinical skills. Researching easiest online nurse practitioner programs can offer insights into programs with manageable admissions criteria without compromising quality.

Overall, combining Immunology knowledge with nursing credentials enhances versatility in healthcare careers. Exploring online accelerated nursing programs for non nurses is a great starting point for those aiming to bridge science and patient care effectively.

Best Scientists Citing Guido Forni

Trending Scientists